Follow the Disc Medicine, Inc. stock price and the full insider trade history of the company, a listed equity based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Market capitalisation: €3bn. The latest transaction was reported on 7 August 2026 (Levée d'options). Among the most active insiders: Quisel John D. Every trade is free.
171
Insider Decl.
n/a
Thresholds
€21m
6 ops.
Buy Volume
€180m
81 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Disc Medicine, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$101.00.
47Σ signal
Buys €21m€180m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Disc Medicine, Inc. is a biopharmaceutical company focused on developing innovative treatments for blood disorders. It is listed on NASDAQ under the ticker symbol IRON.